China Halts Pfizer Diflucan Imports Due to Missing Paperwork

Jan 02, 2014


The China Food and Drug Administration suspended imports of U.S. drugmaker Pfizer Inc's Diflucan on Tuesday, citing a problem with late paperwork.

According to China's FDA, Pfizer's France-based factories failed to submit a supplementary application on time.

Diflucan is used to treat and prevent fungal infection in people with weak immune systems caused by cancer treatment, bone marrow transplant, or diseases such as AIDS.

Pfizer has taken steps to resolve the issue and is working with China's FDA to ensure its products comply with Chinese law.

Read the Reuters press release

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments